These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

943 related items for PubMed ID: 16707558

  • 1. Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.
    Rose-John S, Scheller J, Elson G, Jones SA.
    J Leukoc Biol; 2006 Aug; 80(2):227-36. PubMed ID: 16707558
    [Abstract] [Full Text] [Related]

  • 2. IL-6 transsignaling: the in vivo consequences.
    Jones SA, Richards PJ, Scheller J, Rose-John S.
    J Interferon Cytokine Res; 2005 May; 25(5):241-53. PubMed ID: 15871661
    [Abstract] [Full Text] [Related]

  • 3. Interleukin-6 trans-signalling in chronic inflammation and cancer.
    Scheller J, Ohnesorge N, Rose-John S.
    Scand J Immunol; 2006 May; 63(5):321-9. PubMed ID: 16640655
    [Abstract] [Full Text] [Related]

  • 4. The soluble Interleukin 6 receptor: generation and role in inflammation and cancer.
    Chalaris A, Garbers C, Rabe B, Rose-John S, Scheller J.
    Eur J Cell Biol; 2011 May; 90(6-7):484-94. PubMed ID: 21145125
    [Abstract] [Full Text] [Related]

  • 5. Essential roles of IL-6 trans-signaling in colonic epithelial cells, induced by the IL-6/soluble-IL-6 receptor derived from lamina propria macrophages, on the development of colitis-associated premalignant cancer in a murine model.
    Matsumoto S, Hara T, Mitsuyama K, Yamamoto M, Tsuruta O, Sata M, Scheller J, Rose-John S, Kado S, Takada T.
    J Immunol; 2010 Feb 01; 184(3):1543-51. PubMed ID: 20042582
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-6 trans-signaling in inflammatory bowel disease.
    Mitsuyama K, Sata M, Rose-John S.
    Cytokine Growth Factor Rev; 2006 Dec 01; 17(6):451-61. PubMed ID: 17045835
    [Abstract] [Full Text] [Related]

  • 7. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.
    Atreya R, Mudter J, Finotto S, Müllberg J, Jostock T, Wirtz S, Schütz M, Bartsch B, Holtmann M, Becker C, Strand D, Czaja J, Schlaak JF, Lehr HA, Autschbach F, Schürmann G, Nishimoto N, Yoshizaki K, Ito H, Kishimoto T, Galle PR, Rose-John S, Neurath MF.
    Nat Med; 2000 May 01; 6(5):583-8. PubMed ID: 10802717
    [Abstract] [Full Text] [Related]

  • 8. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G, Küster A, Hemmann U, Keul R, Horsten U, Martens A, Graeve L, Wijdenes J, Heinrich PC.
    J Immunol; 1998 Dec 01; 161(11):6347-55. PubMed ID: 9834125
    [Abstract] [Full Text] [Related]

  • 9. The soluble IL-6 receptors: serum levels and biological function.
    Montero-Julian FA.
    Cell Mol Biol (Noisy-le-grand); 2001 Jun 01; 47(4):583-97. PubMed ID: 11502067
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of interleukin-6-transsignaling via gp130-Fc in hemorrhagic shock and sepsis.
    Mees ST, Toellner S, Marx K, Faendrich F, Kallen KJ, Schroeder J, Haier J, Kahlke V.
    J Surg Res; 2009 Dec 01; 157(2):235-42. PubMed ID: 19589542
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Signal through gp130 activated by soluble interleukin (IL)-6 receptor (R) and IL-6 or IL-6R/IL-6 fusion protein enhances ex vivo expansion of human peripheral blood-derived hematopoietic progenitors.
    Kimura T, Wang J, Minamiguchi H, Fujiki H, Harada S, Okuda K, Kaneko H, Yokota S, Yasukawa K, Abe T, Sonoda Y.
    Stem Cells; 2000 Dec 01; 18(6):444-52. PubMed ID: 11072033
    [Abstract] [Full Text] [Related]

  • 16. In vivo and in vitro activities of the gp130-stimulating designer cytokine Hyper-IL-6.
    Peters M, Blinn G, Solem F, Fischer M, Meyer zum Büschenfelde KH, Rose-John S.
    J Immunol; 1998 Oct 01; 161(7):3575-81. PubMed ID: 9759879
    [Abstract] [Full Text] [Related]

  • 17. Interleukin-6 signalling in juvenile idiopathic arthritis is limited by proteolytically cleaved soluble interleukin-6 receptor.
    Peake NJ, Khawaja K, Myers A, Nowell MA, Jones SA, Rowan AD, Cawston TE, Foster HE.
    Rheumatology (Oxford); 2006 Dec 01; 45(12):1485-9. PubMed ID: 16690760
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-6 and its receptor: from bench to bedside.
    Scheller J, Rose-John S.
    Med Microbiol Immunol; 2006 Dec 01; 195(4):173-83. PubMed ID: 16741736
    [Abstract] [Full Text] [Related]

  • 19. Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells.
    Finotto S, Eigenbrod T, Karwot R, Boross I, Doganci A, Ito H, Nishimoto N, Yoshizaki K, Kishimoto T, Rose-John S, Galle PR, Neurath MF.
    Int Immunol; 2007 Jun 01; 19(6):685-93. PubMed ID: 17496315
    [Abstract] [Full Text] [Related]

  • 20. IL-6/IL-6 receptor system and its role in physiological and pathological conditions.
    Mihara M, Hashizume M, Yoshida H, Suzuki M, Shiina M.
    Clin Sci (Lond); 2012 Feb 01; 122(4):143-59. PubMed ID: 22029668
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.